Skip to main content

and
  1. Article

    Open Access

    Suppression of heparan sulfation re-sensitizes YAP1-driven melanoma to MAPK pathway inhibitors

    Accumulating evidence identifies non-genetic mechanisms substantially contributing to drug resistance in cancer patients. Preclinical and clinical data implicate the transcriptional co-activators YAP1 and its ...

    Sebastian M. Dieter, Domenica Lovecchio, Abhijeet Pataskar, Martina K. Zowada in Oncogene (2022)

  2. Article

    Open Access

    A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis

    Frequent activation of the co-transcriptional factor YAP is observed in a large number of solid tumors. Activated YAP associates with enhancer loci via TEAD4-DNA-binding protein and stimulates cancer aggressiv...

    Li Li, Alejandro P. Ugalde, Colinda L. G. J. Scheele, Sebastian M. Dieter in Genome Biology (2021)

  3. Article

    Open Access

    The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo

    While colorectal cancer (CRC) patients with localized disease have a favorable prognosis, the five-year-survival rate in patients with distant spread is still below 15%. Hence, a detailed understanding of the ...

    Sarah Weber, Sebastian E. Koschade, Christopher M. Hoffmann in BMC Cancer (2019)

  4. No Access

    Article

    Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking

    Hanno Glimm, Jan Korbel and colleagues present a computational framework called cis expression structural alteration map** (CESAM), which they use to identify somatic copy-number alterations affecting cis-regul...

    Joachim Weischenfeldt, Taronish Dubash, Alexandros P Drainas in Nature Genetics (2017)